Consolidated Balance Sheets - USD ($)
|
Dec. 31, 2021 |
Dec. 31, 2020 |
| Current assets: |
|
|
|
| Cash and cash equivalents |
|
$ 271,105,000
|
$ 22,603,000
|
| Accounts receivable, net (net of allowance for doubtful accounts of $6,212 and $5,707, respectively) |
|
103,256,000
|
70,540,000
|
| Other receivables |
|
5,327,000
|
3,152,000
|
| Prepaid expenses |
|
8,819,000
|
3,876,000
|
| Other current assets |
|
2,459,000
|
1,521,000
|
| Total current assets |
|
390,966,000
|
101,692,000
|
| Property and equipment, net |
|
4,534,000
|
4,073,000
|
| Other long term assets |
|
12,173,000
|
6,226,000
|
| Intangible assets, net |
|
155,086,000
|
78,247,000
|
| Goodwill |
|
192,442,000
|
75,736,000
|
| Total assets |
|
755,201,000
|
265,974,000
|
| Current liabilities: |
|
|
|
| Accounts payable |
|
27,155,000
|
19,346,000
|
| Accrued expenses and other current liabilities (Note4) |
|
51,653,000
|
41,669,000
|
| Deferred revenue |
|
11,655,000
|
9,907,000
|
| Contract liabilities, current |
|
4,597,000
|
4,045,000
|
| Debt, current (Note 7 and 13) |
|
0
|
400,000
|
| Total current liabilities |
|
95,060,000
|
75,367,000
|
| Contract liabilities, noncurrent |
|
1,745,000
|
6,261,000
|
| Warrant liabilities |
|
10,820,000
|
4,963,000
|
| Long-term debt (Note 7 and 13) |
|
419,000
|
171,824,000
|
| Other long-term liabilities |
|
24,116,000
|
17,015,000
|
| Total liabilities |
|
132,160,000
|
275,430,000
|
| Redeemable noncontrolling interest |
|
0
|
4,000,000
|
| Series A redeemable convertible preferred stock, $0.0001 par value; 5,000,000 and no shares authorized; 5,000,000 and no shares issued and outstanding, aggregate liquidation preference of $50,000 and $0 as of December 31, 2021 and 2020, respectively(1) |
[1] |
58,205,000
|
|
| Stockholders' deficit: |
|
|
|
| Common stock, $0.0001 par value; 600,000,000 and 424,353,300 shares authorized; 345,788,707 and 217,106,957 shares issued and outstanding as of December 31, 2021 and 2020, respectively(1) |
[1] |
35,000
|
22,000
|
| Additional paid-in capital |
|
1,042,164,000
|
377,134,000
|
| Accumulated other comprehensive loss |
|
(2,061,000)
|
(702,000)
|
| Accumulated deficit |
|
(477,113,000)
|
(392,113,000)
|
| Total Share care stockholders' equity (deficit)(1) |
[1] |
563,025,000
|
(15,659,000)
|
| Non controlling interest in subsidiaries (1) |
|
1,811,000
|
2,203,000
|
| Total stockholders' equity (deficit)(1) |
[1] |
564,836,000
|
(13,456,000)
|
| Total liabilities, redeemable noncontrolling interest, redeemable convertible preferred stock and stockholders' equity (deficit) |
|
$ 755,201,000
|
$ 265,974,000
|
|
|